This document provides interim guidance to laboratories and other stakeholders involved in diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It covers the main considerations for specimen collection, nucleic acid amplification testing (NAAT), antigen (Ag), antibody (Ab) detection and quality assurance. This document will be updated as new information becomes available. 

Resource Links

Resource uploaded by Mike Bailey (Sept. 28, 2020, 3:14 p.m.) and last updated by Mike Bailey (Sept. 28, 2020, 3:15 p.m.)

Resource viewed 131 times